227 related articles for article (PubMed ID: 8578174)
1. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.
Bjøro K; Krarup H; Bell H; Christophersen P; Evensen S; Frøland SS; Laursen A; B vd Lippe B; Maeland A; Ranek L
Scand J Gastroenterol; 1995 Nov; 30(11):1119-24. PubMed ID: 8578174
[TBL] [Abstract][Full Text] [Related]
2. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
3. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
[TBL] [Abstract][Full Text] [Related]
4. Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study.
Bjøro K; Bell H; Myrvang B; Skaug K; Raknerud N; Sandvei P; Størseth S; Ritland S; Lund-Tønnesen S; Bucher A; Hellum KB
Scand J Gastroenterol; 2002 Mar; 37(3):344-9. PubMed ID: 11916198
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C.
Di Marco V; Lo Iacono O; Cammà C; Almasio PL; Vaccaro A; Fuschi P; Giunta M; Fabiano C; Pagliaro L; Craxì A
J Med Virol; 1997 Jan; 51(1):17-24. PubMed ID: 8986944
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.
Pol S; Thiers V; Carnot F; Zins B; Roméo R; Berthelot P; Bréchot C
Nephrol Dial Transplant; 1996; 11 Suppl 4():58-61. PubMed ID: 8918758
[TBL] [Abstract][Full Text] [Related]
7. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
Mizokami M; Orito E; Gibo Y; Suzuki K; Ohba K; Ohno T; Lau JY
Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus RNA and long-term response to recombinant interferon-alpha 2b in patients with chronic hepatitis C.
Tanno H; Fernández JL; Rendo P; del Pino N; Viola L; Terg R; Pérez V
J Viral Hepat; 1995; 2(2):97-102. PubMed ID: 7493304
[TBL] [Abstract][Full Text] [Related]
9. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.
Bell H; Hellum K; Harthug S; Maeland A; Ritland S; Myrvang B; von der Lippe B; Raknerud N; Skaug K; Gutigard BG; Skjaerven R; Prescott LE; Simmonds P
Scand J Infect Dis; 1997; 29(1):17-22. PubMed ID: 9112292
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
Brouwer JT; Nevens F; Kleter B; Elewaut A; Adler M; Brenard R; Chamuleau RA; Michielsen PP; Pirotte J; Hautekeete ML; Weber J; Bourgeois N; Hansen BE; Bronkhorst CM; ten Kate FJ; Heijtink RA; Fevery J; Schalm SW
J Hepatol; 1998 Jun; 28(6):951-9. PubMed ID: 9672169
[TBL] [Abstract][Full Text] [Related]
11. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
Shindo M; Arai K; Sokawa Y; Okuno T
Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
[TBL] [Abstract][Full Text] [Related]
12. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C.
Fargion S; Fracanzani AL; Sampietro M; Molteni V; Boldorini R; Mattioli M; Cesana B; Lunghi G; Piperno A; Valsecchi C; Fiorelli G
Eur J Gastroenterol Hepatol; 1997 May; 9(5):497-503. PubMed ID: 9187884
[TBL] [Abstract][Full Text] [Related]
13. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
[TBL] [Abstract][Full Text] [Related]
14. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
15. Mooren-type hepatitis C virus-associated corneal ulceration.
Wilson SE; Lee WM; Murakami C; Weng J; Moninger GA
Ophthalmology; 1994 Apr; 101(4):736-45. PubMed ID: 7512254
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.
Pol S; Thiers V; Carnot F; Zins B; Romeo R; Berthelot P; Bréchot C
Kidney Int; 1995 May; 47(5):1412-8. PubMed ID: 7637270
[TBL] [Abstract][Full Text] [Related]
17. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of a response to interferon therapy in chronic hepatitis C.
Nomura H; Kimura Y; Tada H; Hisano C; Morita C; Okamoto O; Shiraishi G; Kashiwagi S
J Clin Gastroenterol; 1996 Oct; 23(3):185-90. PubMed ID: 8899499
[TBL] [Abstract][Full Text] [Related]
19. Two years versus six months of interferon therapy for chronic hepatitis C.
Farrell GC
Dig Dis Sci; 1996 Dec; 41(12 Suppl):93S-98S. PubMed ID: 9011483
[TBL] [Abstract][Full Text] [Related]
20. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
Sharvadze LG; Gogichaishvili ShSh; Sakandelidze TsG; Zhamutashvili MT; Chkhartishvili NI
Georgian Med News; 2009 Jan; (166):61-4. PubMed ID: 19202222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
